Search for: "SAS Institute Inc. v. SAS Groupe"
Results 121 - 140
of 156
Sorted by Relevance
|
Sort by Date
5 Oct 2017, 3:33 pm
Proposals to require intermediaries themselves to institute similar automated review, discussed in response to the next question, are even more so. [read post]
3 Nov 2022, 11:00 pm
Brazil has usury rules that restrict the amount of interest rate that a non-banking institution may charge a debtor. [read post]
26 Jul 2015, 4:05 pm
Canada In the case of Kent v Postmedia Network Inc, 2015 ABQB 461 the Court entered summary judgment dismissing the personal claims against two executives of the company which owns the first defendant, the National Post. [read post]
26 Sep 2011, 4:42 am
jovický Budvar, národní podnik v Anheuser-Busch, Inc. [read post]
31 Mar 2020, 4:31 am
The bonds were secured by 50.1 per cent of the share capital of Citgo Holding Inc., a subsidiary of PDVSA. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
5 May 2022, 9:01 pm
J. 363, 368 (2021). [8] Neiman Marcus v. [read post]
25 Oct 2008, 12:18 am
Swisa: implications for India (Spicy IP) Centre for Science and Environment accused of copyright infringement by Mint's editor (Spicy IP) Delhi High Court dicta on fair dealing increases woes of news channels: ESPN Stars Sports v. [read post]
29 Feb 2016, 4:43 pm
This past March, the Court decided Omnicare, Inc. v. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and… [read post]
17 Mar 2020, 1:32 pm
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
15 Mar 2008, 7:00 am
Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt… [read post]
1 May 2020, 2:11 am
Importantly, the 2017 Ordinance also allowed foreign entities conducting activity similar to that of credit institutions, AIF, UCITS, OFS or securitization vehicles to acquire unmatured loan receivables from French credit institutions, AIF, UCITS, OFS or securitization vehicles. [read post]
11 May 2018, 3:22 am
Also, mistaken distributions that are repaid to an HSA are not required to be reported on Form 1099-SA or Form 8889 and are not required to be reported as additional HSA contributions. [read post]
20 Mar 2016, 5:05 pm
” Evidence which was unsealed because a group of media companies, including the Associated Press, sued for access and won, will undoubtedly be key to Gawker in the appeals process. [read post]
18 Jul 2022, 2:46 pm
Furthermore, the campaign group, ShareAction, alongside 117 individuals and 15 institutions, filed a shareholder resolution in early 2021 asking HSBC, Europe’s second largest fossil fuels financier, to publish a strategy and targets to reduce its exposure to fossil fuel assets, starting with coal. [read post]
